ZGNX

Zogenix to Participate in Two Upcoming Investor Conferences

Zogenix to Participate in the BofA Securities 2021 Healthcare Conference

Zogenix, Inc. (ZGNX) CEO Stephen Farr on Q1 2021 Results - Earnings Call Transcript

Zogenix (ZGNX) Reports Q1 Loss, Tops Revenue Estimates

Recap: Zogenix Q1 Earnings

Zogenix Presents New Data at Virtual AAN 2021 Showing Improved Executive Function in Lennox-Gastaut Syndrome (LGS) Patients Treated with FINTEPLA® (Fenfluramine) Oral Solution

Zogenix Presents New Data from a Study Highlighting the Impact of Treatment with FINTEPLA® (Fenfluramine) Oral Solution on Dravet Syndrome Patients, Caregivers, and Families at Virtual AAN 2021